PCSK9 and fatty liver disease: Despite the positive correlation of hepatic PCSK9 and fatty acid synthase mRNA expression in morbidly obese patients, a similar association between these two genes in relation to steatosis stage was not observed and hepatic PCSK9 protein levels even declined with increased severity of liver steatosis [160].